Maryam received her PhD in immunology from Tufts University where she studied the molecular mechanism of antibody somatic hypermutation. Following her graduate studies, she worked as a postdoctoral fellow at Harvard and the University of California San Francisco investigating B cell responses in HIV and lupus. Before joining Prellis, Maryam utilized different platforms to advance antibody discovery and cell therapy in several companies.